Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
J Cachexia Sarcopenia Muscle
.
2015 Dec;6(4):391-2.
doi: 10.1002/jcsm.12080.
Epub 2015 Oct 27.
Authors
Junichi Ishida
1
,
Masaaki Konishi
1
,
Masakazu Saito
1
,
Jochen Springer
1
Affiliation
1
Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen Göttingen, Germany.
PMID:
26674220
PMCID:
PMC4670748
DOI:
10.1002/jcsm.12080
No abstract available